36 results on '"Wang, Anjiang"'
Search Results
2. Paeoniae Decoction restores intestinal barrier dysfunction by promoting the interaction between ILC3 and gut flora
3. Wogonin improves colitis by activating the AhR pathway to regulate the plasticity of ILC3/ILC1
4. A new finding in the key prognosis-related proto-oncogene FYN in hepatocellular carcinoma based on the WGCNA hub-gene screening trategy
5. Cannulation procedure optimization for patients with duodenal papillary tumors
6. Expression and significance of interleukin 25 and its related factors in serum and liver of patients with non-alcoholic fatty liver
7. Efficacy and safety of ERCP in patients with gastroesophageal varices
8. Efficacy and safety of therapeutic ERCP in patients with ectopic papilla of Vater
9. Potential Factors Predicting Histopathologically Upgrade Discrepancies between Endoscopic Forceps Biopsy of the Colorectal Low-Grade Intraepithelial Neoplasia and Endoscopic Resection Specimens
10. Clinical characteristics and efficacy of endoscopic treatment of gastrointestinal ectopic varices: A single-center study
11. Effectiveness and safety of endoscopic treatment for duodenal variceal bleeding: a systematic review
12. Potential factors predicting histopathologically upgrade discrepancies between endoscopic forceps biopsy of the colorectal low-grade intraepithelial neoplasia and endoscopic resection specimens
13. Alpha-fetoprotein is not a risk factor of metastasis for patients with small hepatocellular carcinoma: A propensity- matched analysis
14. Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Metabolic Associated Fatty Liver Disease
15. A New Sight In The Key Prognosis-Related Proto-Oncogene FYN In Hepatocellular Carcinoma Based On WCGNA Hub-Gene Screening Strategy
16. Cannulation procedure optimization for patients with duodenal papillary tumors
17. Bedside Biliary Drainage without Fluoroscopy for Critically Ill Patients
18. Ursolic acid improves the bacterial community mapping of the intestinal tract in liver fibrosis mice
19. Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Metabolic Associated Fatty Liver Disease: A Systematic Review and Meta-analysis.
20. Protective Effect of Ursolic Acid on the Intestinal Mucosal Barrier in a Rat Model of Liver Fibrosis
21. Interaction Mechanisms Between the NOX4/ROS and RhoA/ROCK1 Signaling Pathways as New Anti- fibrosis Targets of Ursolic Acid in Hepatic Stellate Cells
22. Effectiveness and safety of endoscopic treatment for duodenal variceal bleeding: a systematic review.
23. The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria
24. Clinical characteristics and efficacy of endoscopic treatment of gastrointestinal ectopic varices: A single-center study.
25. Efficacy and safety of ERCP in patients with gastroesophageal varices.
26. Ursolic acid ameliorates CCl4‐induced liver fibrosis through the NOXs/ROS pathway
27. Antibiotic resistance and CYP2C19 polymorphisms affect the efficacy of concomitant therapies forHelicobacter pyloriinfection: an open-label, randomized, single-centre clinical trial
28. Mo1767 Genetic Deletion of IL-25 Increases Susceptibility to High-Fat Diet-Induced Metabolic Dysfunction in Mice
29. Neutrophil elastase regulates both type 1 and type 2 immune responses to enteric infection (MPF1P.800)
30. Mice deficient in IL-25 are less susceptible to dextran sulfate sodium-induced colitis (P3270)
31. Mo1993 Parasitic Nematode-Induced Modulation of Body Weight and Associated Metabolic Dysfunction in Mouse Model of Obesity
32. Efficient production of transgenic goat ( Capra hircus) embryos using dual markers
33. Immunohistochemical detection of pepsin in laryngeal mucosa for diagnosing laryngopharyngeal reflux
34. The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria
35. [Down-regulation of IL-25 accompanied by a decrease in the number of M2 macrophages in patients of non-alcoholic fatty liver disease with significant liver fibrosis].
36. Antibiotic resistance and CYP2C19 polymorphisms affect the efficacy of concomitant therapies for Helicobacter pylori infection: an open-label, randomized, single-centre clinical trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.